PC
DRTS icon

Pier Capital’s Alpha Tau Medical DRTS Stock Holding History

Pier Capital’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.7M Buy
+691,939
New +$6.28M 1.15% 33

Other funds holding DRTS

HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $137M AUM
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
WC
Woodstock Corp Boston, Massachusetts $1.2B AUM 26.37% 1-Year Est. Return
FGG
Financial Guidance Group Palm Harbor, Florida $267M AUM 19.62% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

Pier Capital's DRTS Position: Q2 2026 in Review

Pier Capital opened a new position in Alpha Tau Medical (DRTS) in Q2 2026: 691,939 shares worth $8.7M. The stake represents 1.15% of the portfolio and ranks #33 among its holdings.

27 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.

  • Pier Capital held 691,939 shares of Alpha Tau Medical worth $8.7M as of Q2 2026.
  • Alpha Tau Medical was a new Pier Capital position in Q2 2026.
  • Alpha Tau Medical made up 1.15% of Pier Capital's portfolio in Q2 2026, its #33 holding.
  • 27 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.

Based on Pier Capital's 13F filing for Q2 2026, filed 5 Aug 2026.